SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

Learn more about the self-healing hydrogel that could help improve biomedical tools.

Scientists have created a self-healing hydrogel that mimics human skin, offering a breakthrough solution for complete wound ...

Calgary-based NanoTess makes a gel called NanoSALV that's designed to to help heal chronic wounds, skin injuries, infections ...

Strategic Partnership Expands Access to Innovative Wound Care Solution Across CanadaWINNIPEG, Manitoba, March 11, 2025 (GLOBE ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

Researchers develop a stiff, self-healing hydrogel mimicking human skin. Applications include drug delivery, wound healing, & ...

“Entanglement means that the thin polymer layers start to twist around each other like tiny wool yarns, but in a random order ...

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology ...

In a groundbreaking achievement, researchers from Aalto University and the University of Bayreuth have successfully developed a self-healing ...